Biotech · Private company
Diffusion Pharmaceuticals Inc
Track this companyFree. Adds Diffusion Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Trans Sodium Crocetinate plus SOCPhase 3 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Trans Sodium CrocetinatePhase 2 · Interstitial Lung DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Trans-Sodium CrocetinatePhase 2 · Stroke, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Trans Sodium CrocetinatePhase 1 · Healthy Volunteers With Induced HypoxiaClinicalTrials.gov · fetched Nov 12, 2026
- Trans-Sodium CrocetinatePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study of Trans Sodium Crocetinate in Patients With Interstitial Lung DiseasePHASE2 · TERMINATED · started Dec 2, 2021ClinicalTrials.gov NCT05079126 · fetched Nov 12, 2026
- Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at AltitudePHASE1 · COMPLETED · started Nov 9, 2021ClinicalTrials.gov NCT05036980 · fetched Nov 12, 2026
- Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy VolunteersPHASE1 · COMPLETED · started Mar 17, 2021ClinicalTrials.gov NCT04808622 · fetched Nov 12, 2026
- Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected StrokePHASE2 · TERMINATED · started Aug 22, 2019ClinicalTrials.gov NCT03763929 · fetched Nov 12, 2026
- Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only SubjectsPHASE3 · TERMINATED · started Jan 16, 2018ClinicalTrials.gov NCT03393000 · fetched Nov 12, 2026